AstraZeneca

The link between the AstraZeneca vaccine and the UK’s Covid reprieve
Oxford-AstraZeneca vaccine
Getting to grips with . . .

The link between the AstraZeneca vaccine and the UK’s Covid reprieve

Experts question claim that Oxford-developed jab has saved Britain from Europe’s high hospitalisation rates
24 Nov 2021
AstraZeneca Covid-19 antibody treatment ‘more effective than vaccines’
The latest on . . .

AstraZeneca Covid-19 antibody treatment ‘more effective than vaccines’

Trial finds injection reduces risk of symptomatic infection by 83%
19 Nov 2021
Valneva vaccine: why UK ditched jab with ‘stronger immune response’ than AstraZeneca
Engineer looks at samples in vaccine laboratory
In Depth

Valneva vaccine: why UK ditched jab with ‘stronger immune response’ than AstraZeneca

Downing Street accused French manufacturer of breaching contract
19 Oct 2021
How great is the threat of a new vaccine-resistant Covid variant?
Boris Johnson at vaccine clinic
Getting to grips with . . .

How great is the threat of a new vaccine-resistant Covid variant?

Experts voice fears over England’s lockdown-lifting ‘experiment’
9 Jul 2021
Is AstraZeneca’s boss worth his millions?
Pascal Soriot has been CEO of AstraZeneca since 2012
Today’s big question

Is AstraZeneca’s boss worth his millions?

Pascal Soriot’s bonus might be deserved, but that doesn’t mean it’s necessarily wise
14 May 2021
EU ‘preparing to sue’ AstraZeneca over missing Covid doses
European Commission President Ursula von der Leyen
The latest on . . .

EU ‘preparing to sue’ AstraZeneca over missing Covid doses

Ireland’s health minister confirms that Brussels is considering a possible lawsuit over delivery shortfall
22 Apr 2021
The AstraZeneca blood clot risk in context
Oxford-AstraZeneca vaccine
Getting to grips with . . .

The AstraZeneca blood clot risk in context

Experts say odds of adverse side effect are about same as ‘being hit in your home by crashing aeroplane’
8 Apr 2021

Open. Every issue.

Keep an open mind with The Week magazine. Subscribe today and your first 6 issues are completely free.
Under-30s to be offered alternative to AstraZeneca vaccine
Boris Johnson AstraZeneca
Today’s big question

Under-30s to be offered alternative to AstraZeneca vaccine

UK regulator says evidence of a link between the jab and very rare blood clot is ‘firming up’
7 Apr 2021
What Covid vaccines cost - and the countries paying over the odds
People wait to be vaccinated at Salisbury Cathedral
Getting to grips with . . .

What Covid vaccines cost - and the countries paying over the odds

Figures suggest that quicker vaccine rollouts are pay to play
30 Mar 2021
Can Johnson resolve the vaccine shortage?
Boris Johnson at the daily press briefing
Today’s big question

Can Johnson resolve the vaccine shortage?

Government officials keen to avoid ‘war of words’ with Indian government over delivery hold-up
19 Mar 2021
Will vaccine ‘jingoism’ damage the EU?
Ursula von der Leyen
Today’s big question

Will vaccine ‘jingoism’ damage the EU?

Tensions over Covid vaccine supplies have escalated into a battle of words between Brussels and London after Ursula von der Leyen threatened to use em…
18 Mar 2021
The Oxford-AstraZeneca vaccine
Boris Johnson poses with a vial of the Oxford-AstraZeneca vaccine
In Focus

The Oxford-AstraZeneca vaccine

Jewel in the crown of the UK jab campaign has faced harsh scrutiny in Europe
17 Mar 2021
Why has the Oxford vaccine faced so much scrutiny?
Boris Johnson poses with a vial of the Oxford-AstraZeneca vaccine
Today’s big question

Why has the Oxford vaccine faced so much scrutiny?

European safety concerns over vaccine remain despite positive data from UK campaign
16 Mar 2021
AstraZeneca CEO hits back at ‘aggravated’ EU
Pascal Soriot has been CEO of AstraZeneca since 2012
The latest on . . .

AstraZeneca CEO hits back at ‘aggravated’ EU

Pharmaceutical boss denies claim doses have been sold to higher bidder
27 Jan 2021
AstraZeneca delivery delays threatens EU’s Covid vaccination target
European Council President Charles Michel addresses the European parliament
In Brief

AstraZeneca delivery delays threatens EU’s Covid vaccination target

Fresh setback to bloc’s bid to inoculate 70% of adults by summer
25 Jan 2021
Age cap in Oxford vaccine trials casts doubt over results
British pharmaceutical company AstraZeneca
In Brief

Age cap in Oxford vaccine trials casts doubt over results

AstraZeneca failed to disclose that under-55s made up test group in which jab was most effective
26 Nov 2020
Inside the ‘ten-month marathon’ to produce Oxford vaccine
Vials of the Oxford Covid-19 vaccine in front of a sign for Oxford University
In Depth

Inside the ‘ten-month marathon’ to produce Oxford vaccine

Team behind university’s Covid jab admit the 90% effective dosage was discovered by mistake
24 Nov 2020
Will the Oxford Covid vaccine be the true game-changer?
An Oxford scientist working on vaccine development.
In Depth

Will the Oxford Covid vaccine be the true game-changer?

Latest trial results show the university’s jab is up to 90% effective
23 Nov 2020
Oxford Covid-19 vaccine paused over ‘spinal disease’ fears
Vaccine
In Brief

Oxford Covid-19 vaccine paused over ‘spinal disease’ fears

Leaked report says volunteer in UK was left unable to walk after receiving two doses
21 Sep 2020
Oxford scientists: ‘what we’re doing to get a Covid vaccine’
Oxford vaccine
In Depth

Oxford scientists: ‘what we’re doing to get a Covid vaccine’

Researchers working to develop the world’s first Covid-19 vaccine explain how it is being done
10 Sep 2020
Reaction: hopes raised in Oxford vaccine trial - what next?
Coronavirus vaccine
In Depth

Reaction: hopes raised in Oxford vaccine trial - what next?

Results of first human tests fuel hopes that jab may be rolled out by Christmas
21 Jul 2020
Reaction: Covid vaccine hopes raised by Oxford trial results
Coronavirus vaccine
In Depth

Reaction: Covid vaccine hopes raised by Oxford trial results

Scientists from university-led team say their jab may offer ‘double defence’ against coronavirus
16 Jul 2020
AstraZeneca rejects 'final' £69bn offer from Pfizer
British pharmaceutical firm AstraZeneca
In Brief

AstraZeneca rejects 'final' £69bn offer from Pfizer

AstraZeneca claims £55-per-share bid undervalues the company and carries a 'big execution risk'
19 May 2014
State must intervene in the fight for AstraZeneca
AstraZeneca
In Depth

State must intervene in the fight for AstraZeneca

Cosseting national champions isn’t the British way. But is it time to make an exception
2 May 2014
The Week Footer Banner